Beckwith-Wiedemann syndrome: Potassium ascorbate with ribose therapy in a syndrome with high neoplastic risk

Anticancer Research

Volumn 31, Issue 11, 2011, Pages 3973-3976

  Anichini, Cecilia ^a   Lo Rizzo, Caterina ^a   Longini, Mariangela ^a   Paoli, Guido ^b   Di Bartolo, Rosanna Maria ^a   Proietti, Fabrizio ^a   Buonocore, Giuseppe ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b Valsè Pantellini Foundation   (Italy)

Author keywords

Beckwith Wiedemann syndrome; Oxidative stress; Potassium ascorbate

Indexed keywords

ADVANCED OXIDATION PROTEIN PRODUCT; ASCORBIC ACID; CARBONYL DERIVATIVE; HYDROPEROXIDE; ISOPROSTANE DERIVATIVE; RIBOSE; THIOL DERIVATIVE;

ARTICLE; BECKWITH WIEDEMANN SYNDROME; CANCER RISK; CASE REPORT; CLINICAL FEATURE; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; TREATMENT DURATION;

ADULT; ASCORBIC ACID; BECKWITH-WIEDEMANN SYNDROME; FEMALE; GENOMIC IMPRINTING; HUMANS; INFANT; INFANT, NEWBORN; OXIDATIVE STRESS; POTASSIUM COMPOUNDS; PROGNOSIS; RIBOSE; RISK FACTORS;

EID: 83055174810     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Graham JM and Rimoin L: Prenatal overgrowth syndrome. Principles and Practice of Medical Genetics, 4th edition, London. Rimoin DL, Connor JM, Pyeritz RE, Korf BR. Churchill Livingstone, pp. 1077-1079, 2002.
2. Algar EM, St. Heaps L, Darmanian A, Dagar V, Prawitt D, Peters GB and Collins F: Paternally inherited submicroscopic duplication at 11p15.5 implicates insulin like growth factor II in overgrowth and Wilms' tumorigenesis. Cancer Res 67(5): 2360-2365, 2007. (Pubitemid 46424258)
3. Evans MD, Dizdaroglu M and Cooke MS: Oxidative DNA damage and disease: induction, repair and significance. Mutat Res 567: 1-61, 2004. (Pubitemid 39162992)
4. Tudek B, Winczura A, Janik J, Siomek A, Foksinski M, Olinski R: Involvement of oxidatively damaged DNA and repair in cancer development and aging. Am J Transi Res 2(3): 254-284, 2010.
5. Halliwell B: Biochemistry of oxidative stress. Biochem Soc Trans 35(Pt 5): 1147-50, 2007.
6. Ziech D, Franco R, Georgakilas AG, Georgakilas S, Malamou Mitsi V, Shoneveld O, Pappa A and Panayiotidis MI: The role of reactive oxygen species and oxidative stress in environmental carcinogenesis and biomarker development. Chem Biol Interact 188(2): 334-339, 2010.
7. Sparago A, Russo S, Cerrato F, Ferraiuolo S, Castorina P, Selicorni A, Schwienbacher C, Negrini M, Ferrero GB, Silengo MC, Anichini C, Larizza L and Riccio A: Mechanism causing imprinting defects in familial Beckwith-Wiedemann syndrome with Wilms' tumour. Hum Mol Genet 16(3): 254-264, 2007. (Pubitemid 46323182)
8. Cooper WN, Luharia A, Evans GA, Raza H, Haire AC, Grundy R, Bowdin SC, Riccio A, Sebastio G, Bliek J, Schofield PN, Reik W, Macdonald F and Maher ER: Molecular subtypes and phenotypic expression of Beckwith-Wiedemann syndrome. Eur J Hum Gen 13: 1025-1032, 2005. (Pubitemid 43073609)
9. Murrell A, Heeson S, Cooper WN, Douglas E, Apostolidou S, Moore GE, Maher ER and Reik W: An association between variants in the IGF2 gene and Beckwith-Wiedemann syndrome: interaction between genotype and epigenotype. Hum Mol Genet 13(2): 247-255, 2004. (Pubitemid 38111362)
10. Buonocore G, Perrone S, Longini M, Paffetti P, Vezzosi P, Gatti M G, and Bracci R: Non protein bound iron as early predictive marker of neonatal brain damage. Brain 126(Pt 5): 1224-1230, 2003. (Pubitemid 36522963)
11. Buonocore G, Perrone S, Longini M, Terzuoli L and Bracci R: Total hydroperoxide and advanced oxidation protein products in preterm hypoxic babies. Pediatr Res 47: 221-224, 2000. (Pubitemid 30075632)
12. Halliwell B and Lee CY: Using isoprostanes as biomarkers of oxidative stress: some rarely cosidered issues. Antioxid Redox Signal 13(2): 145-156, 2010.
13. Negre-Salvayre A, Auge N, Basaga H, Boada J,Brenke R, Chappie S, Cohen G, Feher J, Grune T, Lengyel G, Mann GE, Pamplona R, Poli G, Portero-Otin M, Riahi Y, Salvayre R, Sasson S, Serrano J, Shamni O, Siems W, Siow RC, Wiswedel I, Zarkovic K and Zarkovic N: Pathological aspects of lipid peroxidation. Free Radic Res 44(10): 1125-1171, 2010.
14. Paffetti P, Perrone S, Longini M, Ferrari A, Tanganelli D, Marzocchi B and Buonocore G: Non-protein-bound iron detection in small samples of biological fluids and tissues. Biol Trace Elem Res 112(3): 221-232, 2006. (Pubitemid 44624062)
15. Milne GL, Sanchez SC, Musiek ES and Morrow JD: Quantification of F2-isoprostanes as a biomarker of oxidative stress. Nature Protocols 2(1): 221-226, 2007. (Pubitemid 47040087)
16. Ellman GL: Tissue sulfhydryl groups. Arch Biochem Biophys 82: 70-77, 1959.
17. Jankov RP, Negus A and Tanswell AK: Antioxidants as therapy in the newborn: some words of caution. Pediatr Res 50(6): 681-687, 2001. (Pubitemid 33121635)
18. Hertz N and Lister RE. Improved survival in patients with endstage cancer treated with coenzyme Q(10) and other antioxidants: a pilot study. J Int Med Res 37(6): 1961-1971, 2009.
19. Delia Croce C, Poi G, Caltavuturo L, Badi M, Paoli G and Bronzetti G: Protective effect of potassium ascorbate in different strains of yeasts saccharomyces Cerevisiae; edited by Giorgio Bronzetti, Linette R.Ferguson and Silvio De Flora; VIIIth International Conference on mechanism of antimutagenesis and anticarcinogenesis, Pisa.
20. Croci S, Pedrozzi G, Paoli G, Monetti D, Bronzetti G and Ortalli I: Potassium ascorbate as protective agent in oxidation of red cells. Abstract of the International Conference on antioxidants in cancer prevention and therapy, Atene 2001.
21. Paoli G: The biomagnetic nature of cancer and the role of potassium ascorbate and ribose against cellular degeneration. Journal of New Energy 7(3): 114-119, 2003.
22. Sies H: Role of reactive oxygen species in biological processes. Klin Wochenschr 69(21-23): 965-968, 1991.
23. Takemura Y, Satoh K, Hamada H, Sekido Y and Kubiota S: High dose of ascorbic acid induces cell death in mesothelioma cells. Biochem Biophys Res Commum 394(2): 249-253, 2010.
24. Pollard HB, Levine MA, Eidelman O and Pollard M: Pharmacological ascorbic acid suppresses syngeneic tumor growth and metastates in hormone-refractory prostate cancer. In Vivo 24(3): 249-255, 2010.